Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466180
Status:
COMPLETED
Last Update Posted:
2010-10-28
First Post:
2007-04-25
Brief Title:
Adherence Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
Sponsor:
University Hospital Caen
Organization:
University Hospital Caen
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
POSOVIR
Brief Summary:
Taking antiretrovirals once-a-day is considered the simpler way to improve adherence However it is not know if this assertion apply to patients taking their medication twice-a-day who change to once-a-day
We hypothesized that once-daily dosing improves adherence
We hypothesized that once-daily dosing improves adherence
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None